Description
Iguratimod is an antirheumatic agent, acts as an inhibitor of COX-2, with an IC50 of 20 μM (7.7 μg/mL), but shows no effect on COX-1. Iguratimod also inhibits macrophage migration inhibitory factor (MIF) with an IC50 of 6.81 μM.
PreparationUse
anti-inflammatory. Reduces the production of prostaglandins in inflammatory tissues by selective inhibition of cyclooxygenase-2; Inhibits the release of bradykinin from inflammatory tissues; Inhibit antigen-specific T cell proliferation; Reduces the level of pro-inflammatory factors produced by B cells in patients with rheumatoid arthritis; stimulates osteoblast differentiation and bone construction; Inhibits synovial cell co-stimulatory factor expression and cytokine production.